Chemours

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Chemical Solutions segment refers to the sale of chemicals used in industrial and consumer applications in the Americas. The company was founded on February 18, 2014, and is headquartered in Wilmington, DE.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Chemours overcomes Q4 challenges, eyes growth and sustainability in 2023

Chemours had a tough Q4 but a successful year overall, with a focus on margin improvement, growth in key businesses, and addressing legacy issues. The company is optimistic about 2023, emphasizing sustainability-led growth and returning value to shareholders.

Chemours reports strong Q1 performance, navigates challenges, eyes growth opportunities

Chemours' Q1 2023 Earnings Call highlighted strong performance, reaffirmed guidance, and emphasized margin improvement strategies. The company faces challenges from macroeconomic uncertainties and inflationary pressures but sees opportunities in sustainable initiatives and market-led innovation. Chemours remains confident in its full-year outlook and growth strategies.

Chemours reports record results, eyes cost reduction and innovation

Chemours had a strong quarter with record results and notable achievements in facility closures and settlements. While challenges lie ahead with a weaker second half expected, the company remains focused on shareholder value and strategic priorities. Opportunities in cost reduction, innovation, and market leadership position Chemours for future growth.

Chemours addresses challenges, eyes growth in sustainable solutions market

Chemours Company navigated challenges in Q3 2023, with a focus on long-term shareholder value and strategic transformation for performance improvement.
Strong performance in Performance Solutions and TSS business, alongside cost savings initiatives, position Chemours for future growth and margin recovery.
Management's commitment to driving value for shareholders amidst industry challenges underscores a proactive approach to addressing market dynamics.

Chemours reports Q4 sales growth, addresses TiO2 market challenges

Chemours is navigating challenges in the TiO2 market while focusing on cost reduction and growth opportunities in other segments. The company aims to maintain competitiveness through strategic decisions and investments in R&D. Analysts' inquiries during the earnings call highlighted concerns about leadership stability and various segment dynamics.

Chemours reports mixed Q1 results, eyes sequential growth in 2024

Chemours' Q1 2024 performance reflected mixed results across segments, with a focus on cost efficiencies, transformation plans, and maintaining liquidity amidst declining net sales and EBITDA.
Despite challenges in certain segments and market uncertainties, Chemours remains optimistic about sequential growth in the second quarter, aiming for significant EBITDA potential in 2024 and long-term financial improvement.
Strategic strengths in cost management, growth initiatives, and market opportunities position Chemours to navigate challenges, drive growth, and enhance profitability in a dynamic business environment.

Chemours exceeds volume expectations amidst challenges, anticipates sequential decline

Chemours demonstrated resilience and growth in key product lines despite facing challenges in Q1 and Q2.
The company's cost-saving efforts and recovery in certain segments highlight its ability to adapt to market conditions.
While financial results were impacted by one-time costs and a decline in net sales, Chemours maintained a strong net leverage ratio.
Anticipated sequential decline in net sales for Q3 underscores the need for strategic planning and operational optimization.

Chemours reports strong Q3 performance amidst strategic growth initiatives

Chemours' Q3 performance reflects operational strength and growth in key segments.
Challenges include declines in net sales for TSS and TT in Q4 and a net loss.
Opportunities exist in cost savings, growth in Opteon refrigerants, and strategic investments.
Overall, Chemours remains confident in its strategy to drive shareholder value.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Other. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Other segment consists of performance chemicals and intermediates business. The company was founded on February 18, 2014, and is headquartered in Wilmington, DE.

Chemours gained 41% in 2020 but has retraced -16% since its Q4 '20 earnings report. It yields 4.2%/year, but its options have much higher yields of 7.5% to 9.5% in under four months.

Chemours: 15% Below Lowest Price Target, High Options Yields

e.l.f. Beauty

Greenbrier Companies

Olin

Weyerhaeuser

As bond yields continue to rise, Q.ai's Artificial Intelligence has dug up the details to find you today's best short plays.

Top Stocks To Short Today As Bond Yields Beat Up Tech Stocks Again

Chemours (CC) is well positioned to outperform the market, as it exhibits above-average growth in financials.

3 Reasons Why Growth Investors Shouldn't Overlook Chemours (CC)

Mosaic

Resideo Technologies Inc

Zillow

The major indices are broadly in the red right now, but the deep learning algorithms at Q.ai have assessed the market to give you today's top shorts.

Top Stocks To Short Today As Inflation Fears Cause Indices To Retreat

The Chemours Company (CC) CEO Mark Vergnano on Q4 2020 Results - Earnings Call Transcript

Chemours' (CC) fourth-quarter performance benefits from a global macroeconomic recovery.

Chemours (CC) Tops Earnings and Revenue Estimates in Q4

Shares of Chemours Co. rose nearly 5% in the extended session Thursday after the maker of Teflon and other compounds swung to a fourth-quarter profit and reported quarterly sales in line with Wall Street expectations. Chemours said it earned $19 million, or 11 cents a share, in the quarter, versus a loss of $317 million in the year-ago quarter.

Chemours stock jumps 5% as Q4 sales nearly back at pre-pandemic levels

WILMINGTON, Del., Feb. 11, 2021 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions today announced its...

The Chemours Company Reports Strong Fourth Quarter and Full Year 2020 Results with Solid Momentum Across Core Markets

Chemours' (CC) fourth-quarter 2020 results are likely to reflect recovery in demand across all markets and regions as well as benefits from cost-cutting measures.

Chemours (CC) to Post Q4 Earnings: What's in the Cards?

Corteva Inc

DuPont de Nemours

DuPont de Nemours Inc. , Corteva Inc. and Chemours Co. announced Friday an agreement to settle legal disputes, and to establish a cost-sharing arrangement related to PFAS liabilities. Under terms of the agreement, expenses will be split 50-50, with DuPont and Corteva responsible for one half and Chemours responsible for the other half.

DuPont, Corteva and Chemours settle PFAS legal disputes, with expenses capped at $4 billion

WILMINGTON, Del., Jan. 22, 2021 /PRNewswire/ -- DuPont de Nemours, Inc. (NYSE: DD), Corteva, Inc. (NYSE: CTVA) and The Chemours Company (NYSE: CC) today announced they have entered into a binding memorandum of understanding containing a settlement to resolve legal disputes originating...

DuPont, Corteva, and Chemours announce resolution of legacy PFAS claims

WILMINGTON, Del., Jan. 21, 2021 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Titanium Technologies, and Chemical Solutions, announced it will release fourth quarter 2020 financial results after...

Chemours Announces Dates for Fourth Quarter 2020 Earnings Release and Webcast Conference Call

Is (CC) Outperforming Other Basic Materials Stocks This Year?

Is The Chemours (CC) Outperforming Other Basic Materials Stocks This Year?

D.R. Horton

DocuSign

Harley-Davidson

Expectations about stimulus package, Fed's supportive stance, and vaccine rollout have helped investors remain optimistic, which calls for investing in growth stocks like D.R. Horton (DHI) and DocuSign (DOCU).

Wall Street Unfazed by Lingering Unease in Washington: 5 Picks

Chemours (CC) possesses solid growth attributes, which could help it handily outperform the market.

3 Reasons Why Chemours (CC) Is a Great Growth Stock

Does Chemours (CC) have what it takes to be a top stock pick for momentum investors? Let's find out.

Are You Looking for a Top Momentum Pick? Why Chemours (CC) is a Great Choice

Chemours (CC) gains on a recovery in demand from the coronavirus-induced slowdown, strong execution and its cost-reduction measures.

Chemours (CC) Stock Rallies 79% in 6 Months: What's Driving It?

Dana Incorporated

Huntsman

Lear

Magna International

Vista Outdoor

Investors target stocks that have been on a bullish run, lately. Stocks seeing price strength have higher chances of carrying the momentum ahead.

6 Stocks Trading Near 52-Week Highs That Can Appreciate Further

Cabot

Celanese

PPG Industries

The chemical industry has recovered from the pandemic-led slump and looks set for an upturn this year on a rebound in end-market demand. CBT, HUN, CC, PPG and CE to gain from the industry's recovery.

Global Chemical Output Leaps for Sixth Straight Month: 5 Picks

WILMINGTON, Del., Jan. 5, 2021 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Fluoroproducts and Chemical Solutions, applauds the 116th Congress in its recent passing of the bipartisan American...

Chemours is Prepared to Support US Industry with Pivotal Next Generation, Low Global Warming Potential Technologies

Element Solutions Inc

Quaker Chemical

Shin-Etsu Chemical Co Ltd

Covestro AG

A rebound in China, demand upturn across major markets and recovering manufacturing activities augur well for the chemical industry heading into 2021.

5 Chemical Stocks Poised to Maintain Winning Streak in 2021

Koppers

4 Diversified Chemical Stocks Set to Ride the Industry's Upturn

Let's see if The Chemours Company (CC) stock is a good choice for value-oriented investors right now from multiple angles.

Is Chemours Company (CC) a Good Value Investor Stock Now?

Trinseo PLC

The U.S. chemical industry is poised for an upturn next year on a rebound across major end-markets and a recovery in chemical exports.

US Chemical Industry Set for Strong Rebound in 2021: 5 Picks

Chemours (CC) gains on a recovery in demand from the coronavirus-induced slowdown and its cost-reduction measures.

News for Chemours Stock (CC)